Decheng Capital
Decheng Capital is a venture investment firm founded in 2012 that provides capital and strategic support to early-stage life science companies and growth-stage healthcare companies. The firm reports approximately $2.1 billion in capital and positions itself as a partner to entrepreneurs, scientists and strategic collaborators to support company building and exits.
Decheng Capital
Services
Equity funding (early-stage and growth)
Provides capital to early-stage life science companies and growth-stage healthcare companies.
Strategic support and partnerships
Works with portfolio management teams on strategic initiatives and facilitates partnerships with industry players and scientific collaborators.
Board membership and operational support
Firm principals serve on portfolio company boards and provide governance and operating guidance.
Network access
Connects companies to limited partners, strategic partners and scientific advisors.
Equity funding (early-stage and growth)
Provides capital to early-stage life science companies and growth-stage healthcare companies.
Strategic support and partnerships
Works with portfolio management teams on strategic initiatives and facilitates partnerships with industry players and scientific collaborators.
Board membership and operational support
Firm principals serve on portfolio company boards and provide governance and operating guidance.
Network access
Connects companies to limited partners, strategic partners and scientific advisors.
Portfolio
#Biopharma
#Biopharma
#Diagnostics and Tools
#Biopharma
#Diagnostics and Tools
#Biopharma
#Biopharma
#Diagnostics and Tools
#Biopharma
#Diagnostics and Tools